CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (8,173,389)	$ (1,347,957)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for doubtful accounts	435,838	64,811
Depreciation and amortization	351,396	334,434
Gain on sale of marketable securities	0	(49,791)
Loss on disposal of assets	476,745	0
Deferred income taxes	(127,736)	(51,922)
Stock-based compensation expense	1,103,976	1,258,848
Loss on debt extinguishment, net	266,366	0
Amortization of deferred financing costs	94,912	121,578
Write-off of capitalized offering costs	513,646	0
Amortization of debt discount, net of out of period correction	(29,984)	400,394
Change in fair value of warrant and conversion feature liability	408,692	(833,545)
Impairment of goodwill and intangible assets	207,285	0
Changes in assets and liabilities:
Accounts receivable	(27,195)	(912,205)
Other receivables	283,704	(188,236)
Due from affiliates	15,892	55,358
Prepaid expenses and other current assets	(92,182)	(118,054)
Deferred financing costs	(43,330)	0
Other assets	3,181	(106,510)
Accounts payable and accrued liabilities	1,024,991	851,277
Deferred rent liability	57,907	0
Medical liabilities	1,410,160	249,610
Net cash used in operating activities	(1,839,125)	(271,910)
Cash flows from investing activities:
Acquisitions, net of $0 and $660,893 of cash and cash equivalents acquired during the year ended March 31, 2016 and 2015, respectively	0	(3,356,145)
Proceeds from the sale of ACC assets	15,000	0
Increase in cash on consolidation of variable interest entity	0	271,395
Proceeds from sale of marketable securities	0	438,884
Property and equipment acquired	(262,108)	(44,509)
Increase in restricted cash	0	(510,000)
Net cash used in investing activities	(247,108)	(3,200,375)
Cash flows from financing activities:
Proceeds from issuance of convertible note payable	0	2,000,000
Repayments on convertible notes	(470,000)	0
Proceeds from notes payable	100,000	0
Proceeds from line of credit	0	1,000,000
Repayments on lines of credit	(1,006,000)	0
Principal payments on notes payable	(6,527,500)	(936,083)
Contributions by noncontrolling interest	0	725,278
Distributions to noncontrolling interest	(702,642)	(600,000)
Debt issuance costs	0	(533,646)
Proceeds from issuance of common stock	200,000	0
Payment to noncontrolling interest for equity interest	(251,852)	(500)
Net cash provided by financing activities	6,342,001	1,655,049
Net change in cash and cash equivalents	4,255,768	(1,817,236)
Cash and cash equivalents, beginning of year	5,014,242	6,831,478
Cash and cash equivalents, end of year	9,270,010	5,014,242
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	521,341	768,845
Income taxes paid	176,587	32,197
NON-CASH FINANCING ACTIVITIES:
Convertible note warrant	0	487,620
Convertible note conversion feature	0	578,155
Acquisition related warrant consideration	0	132,000
Acquisition related consideration fair value of units issued by consolidated subsidiary	0	274,148
Acquisition related deferred tax liability	0	218,183
Pre-acquisition net equity of noncontrolling interest in variable interest entity	0	191,154
Issuance of common stock on conversion of 8% warrants and notes	3,060,000	0
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest	553,851	0
Change in non-controlling interest ownership	338,032	0
Tenant improvement allowance	659,360	0
Note receivable related to sale of ACC asset	51,000	0
Convertible debt reclassified to accounts payable	100,000	0
Common stock issued for acquisition of intangible assets	1,312,500	0
Series A Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from the issuance of preferred stock and warrants	10,000,000	0
Series B Preferred Stock [Member]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	0	0
Cash flows from financing activities:
Proceeds from the issuance of preferred stock and warrants	4,999,995	0
NON-CASH FINANCING ACTIVITIES:
Acquisition related consideration fair value of units issued by consolidated subsidiary		0
Pre-acquisition net equity of noncontrolling interest in variable interest entity		$ 0
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest	$ 0